137 related articles for article (PubMed ID: 19615202)
1. [The clinical study for reducing bladder cancer recurrence after surgical treatment for renal pelvic carcinoma].
Miao M; Kong CZ; Li ZH; Liu XK; Sun ZX
Zhonghua Wai Ke Za Zhi; 2009 May; 47(10):728-30. PubMed ID: 19615202
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract.
Terakawa T; Miyake H; Muramaki M; Takenaka A; Hara I; Fujisawa M
Urology; 2008 Jan; 71(1):123-7. PubMed ID: 18242379
[TBL] [Abstract][Full Text] [Related]
3. [Clinical research on prevention of recurrence of superficial bladder cancer--comparative study on clinical efficacy of bleomycin intravesical instillation and bestatin].
Kumamoto Y; Tsukamoto T; Tamiya T; Takatsuka K; Furuya S; Yokoyama E; Honma A; Aoyama T; Tanda H; Kato S
Hinyokika Kiyo; 1985 Oct; 31(10):1861-83. PubMed ID: 2418659
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for intravesical recurrence following urothelial carcinoma of the upper urinary tract: no relationship to the mode of surgery.
Koda S; Mita K; Shigeta M; Usui T
Jpn J Clin Oncol; 2007 Apr; 37(4):296-301. PubMed ID: 17513309
[TBL] [Abstract][Full Text] [Related]
5. Pattern of intravesical recurrence after surgical treatment for urothelial cancer of the upper urinary tract: a single institutional retrospective long-term follow-up study.
Takaoka E; Hinotsu S; Joraku A; Oikawa T; Sekido N; Miyanaga N; Kawai K; Shimazui T; Akaza H
Int J Urol; 2010 Jul; 17(7):623-8. PubMed ID: 20412341
[TBL] [Abstract][Full Text] [Related]
6. [Clinical investigation on the effect of intravesical instillation of antifibrinolytic agents with bacillus Calmette-Guerin on preventing bladder cancer recurrence].
Ding GQ; Shen ZJ; Lu J; Jin XD; Chen J; Shi SF
Zhonghua Wai Ke Za Zhi; 2005 Nov; 43(22):1457-60. PubMed ID: 16318813
[TBL] [Abstract][Full Text] [Related]
7. [Prophylactic effect of inductive intravesical instillation of Bacillus Calmette-Guerin on postoperative recurrence of bladder cancer].
Yi SH; Ye G; Wang XW; Jin HS; Zhang YN; Yan ZL
Ai Zheng; 2008 Nov; 27(11):1208-11. PubMed ID: 19000455
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of ureteral stripping versus open ureterectomy for nephroureterectomy in patients with transitional carcinoma of the renal pelvis.
Saika T; Nishiguchi J; Tsushima T; Nasu Y; Nagai A; Miyaji Y; Maki Y; Akaeda T; Saegusa M; Kumon H;
Urology; 2004 May; 63(5):848-52. PubMed ID: 15134963
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma.
Soga N; Arima K; Sugimura Y
Int J Urol; 2008 Sep; 15(9):800-3. PubMed ID: 18651862
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract.
Matsui Y; Utsunomiya N; Ichioka K; Ueda N; Yoshimura K; Terai A; Arai Y
Urology; 2005 Feb; 65(2):279-83. PubMed ID: 15708038
[TBL] [Abstract][Full Text] [Related]
11. [Recurrent urothelial cancer after resection of ureteral carcinoma].
Kong C; Ci J; Liu T
Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):465-7. PubMed ID: 10920948
[TBL] [Abstract][Full Text] [Related]
12. Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial).
O'Brien T; Ray E; Singh R; Coker B; Beard R;
Eur Urol; 2011 Oct; 60(4):703-10. PubMed ID: 21684068
[TBL] [Abstract][Full Text] [Related]
13. Intravesical epirubicin treatment following TUR in superficial bladder tumours.
Imamoğlu MA; Bakirtaş H; Yiğitbaşi O; Ersoy H; Sertçelik AN
Arch Esp Urol; 2001 Dec; 54(10):1147-53. PubMed ID: 11852530
[TBL] [Abstract][Full Text] [Related]
14. [Intravesical instillation of epirubicin in the prophylactic treatment of recurrent superficial bladder cancer].
Kobayashi M; Sugaya Y; Yuzawa M; Morita T; Kobayashi Y; Tokue A
Hinyokika Kiyo; 1998 Dec; 44(12):861-4. PubMed ID: 10028430
[TBL] [Abstract][Full Text] [Related]
15. Immunoprophylactic intravesical application of bacillus Calmette-Guerin after transurethral resection of superficial bladder cancer.
Librenjak D; Situm M; Eterovic D; Dogas Z; Gotovac J
Croat Med J; 2003 Apr; 44(2):187-92. PubMed ID: 12698510
[TBL] [Abstract][Full Text] [Related]
16. Bladder tumour development after urothelial carcinoma of the upper urinary tract is related to primary tumour location.
Zigeuner RE; Hutterer G; Chromecki T; Rehak P; Langner C
BJU Int; 2006 Dec; 98(6):1181-6. PubMed ID: 17125475
[TBL] [Abstract][Full Text] [Related]
17. Pathological characteristics and clinical course of bladder tumour developing after nephroureterectomy.
Abe T; Shinohara N; Harabayashi T; Sazawa A; Akino T; Ishikawa S; Kubota K; Matsuno Y; Osawa T; Shibata T; Toyoda Y; Shinno Y; Kamota S; Minami K; Sakashita S; Kumagai A; Takada N; Togashi M; Sano H; Mori T; Nonomura K
BJU Int; 2010 Apr; 105(8):1102-6. PubMed ID: 19725822
[TBL] [Abstract][Full Text] [Related]
18. [A clinical study of associated bladder cancer in patients with renal pelvic and ureteral cancer].
Togashi M; Toyota K; Kashiwagi A; Asano Y; Nagamori S; Seki T; Koyanagi T; Maru A
Hinyokika Kiyo; 1990 Oct; 36(10):1141-7. PubMed ID: 2264542
[TBL] [Abstract][Full Text] [Related]
19. [Intravesical BCG therapy for superficial bladder cancer].
Segawa N; Iwamoto Y; Azuma H; Yamamoto K; Ueda H; Katsuoka Y
Hinyokika Kiyo; 1998 Sep; 44(9):627-31. PubMed ID: 9805666
[TBL] [Abstract][Full Text] [Related]
20. [Carcinoma recurrence rates after laparoscopic nephroureterectomy in patients undergoing transurethral incision of the ureteral orifice and open excision of bladder cuff].
Zhang DX; Shen HL; Lü WC; Tian Y; Li J; Hao GY; Xiao J; DU LD
Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(40):2854-6. PubMed ID: 19080497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
